Microbiology & Infectious Diseases

Delayed routine infant vaccinations strongly predict missed MMR doses by age 2, raising concern as post-pandemic declines coincide with rising measles cases in the USA.

Adult bacterial meningitis continues to carry high mortality and neurological complications, especially from Listeria, Streptococcus pyogenes, and pneumococcus.

New evidence shows human rhinovirus can directly infect the lower lungs and cause pneumonia in adults, challenging its reputation as a mild cold virus.

Ants produce diverse, targeted antimicrobial compounds that inhibit drug-resistant pathogens, including Candida auris, offering insights for new antibiotics.

A multi-omics study identifies causal genes and biological subtypes of Long COVID, revealing new therapeutic targets for personalised care.

Novel multistage malaria vaccine demonstrates over 50% efficacy following controlled human malaria infection, supporting further trials in children.

Baloxavir significantly reduces hospitalisations in influenza outpatients compared with oseltamivir, highlighting its value during flu season.

WHO’s review of studies from 2010–2025 confirms vaccines, including thiomersal-containing ones, are not associated with autism.